Browsing articles from "October, 2012"

2013 Members Report

In Defense of Good Medicine

Favorable operating performance and positive claims experience in 2012 and 2013 once again places OMIC among the most financially sound carriers in America. We could never have achieved such superior results without the support of policyholders like you, and, therefore, we are pleased to announce that OMIC’s Board of Directors approved a 25% dividend for all active physician-insureds as of December 31, 2013, to be applied as a credit to your 2014 renewal premium.

In addition, there will be no rate changes for 2014; your competitive 2013 rates will be extended through your 2014 policy period. OMIC has maintained competitive rates and declared more than $30 million in dividend credits since 2005. There is no other carrier in America that has produced such consistent value for policyholders.

We are also pleased to present the 2013 OMIC Members Report, In Defense of Good Medicine. This year’s report highlights OMIC’s exceptional claims experience because the financial health of your company is directly related to our successful management of ophthalmic claims and lawsuits. OMIC is ranked #1 among our peers in claim performance, which we believe is largely the result of the high participation of our insureds in risk management programs. These programs provide our insureds with both immediate and longterm benefits in the form of premium discounts and lower liability risk.

Click download above to access the report (in PDF format). For a printed copy of this report, please contact OMIC.

Copyright and Disclaimer

Copyright Statement

OMIC, the Ophthalmic Mutual Insurance Company, has exclusive rights under U.S. and foreign copyright laws. Unless otherwise indicated, all materials on these pages are copyrighted by the Ophthalmic Mutual Insurance Company. All rights reserved. No part of these pages, either text or image may be used for any purpose other than personal use. Therefore, reproduction, modification, storage in a retrieval system or retransmission, in any form or by any means, electronic, mechanical, or otherwise, for reasons other than personal use, is strictly prohibited without prior written permission.

Disclaimer

This online information is published by OMIC, the Ophthalmic Mutual Insurance Company, a risk retention group, for educational purposes only. It is intended solely to provide general information on a number of medical, legal, and insurance issues. It is not intended to constitute medical, legal, or other professional advice and should not be relied upon as a source for such advice. If such advice is desired or needed, a doctor, attorney, insurance or other professional should be consulted.

OMIC makes all reasonable efforts to provide content that is accurate and reliable as of the date of writing. Changes may be made to the information upon which the content is based, and these changes may or may not be incorporated into the content of this website. OMIC may amend the content of this website at any time, without notice. OMIC maintains archives of its previously published materials. Such materials will not be updated even if information changes. For example, if OMIC updates its underwriting requirements for refractive surgery, it will not update a previously published article on the subject. For questions concerning insurance documents, such as the policy or Bylaws, please reference the documents in effect for the applicable time period, which are posted on OMIC’s website or can be requested via email at omic@omic.com.  The content of this website could also include technical inaccuracies or typographical errors. If you find any errors or omissions, we encourage you to report them by e-mail to omic@omic.com.

OMIC gives no assurance or warranty, expressed or implied, regarding the accuracy, adequacy, completeness, legality, or reliability of any information on its website. The information is provided “as is.” All warranties of any kind, express or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses, and non-infringement of proprietary rights, are disclaimed.

Privacy Statement

OMIC (“we” or “us”) is committed to keeping your personally identifiable information private. This privacy statement describes how OMIC uses information we collect about you through our website and how we use your email address to communicate with you. It also explains the choices you can make about how we use your information and email address.

OMIC is the sole owner of the information collected on its website. This privacy statement applies only to information collected by this website.

Information We Collect

Automatically Collected Information

As is true of most websites, each time you visit OMIC’s website, we gather such information as your domain name, your internet protocol (IP) address, and your browser type, and store it in log files. Our server software also records how often you access our web pages. In addition, in order to reproduce your information on the Application Downloads Request Information Form and thus save you the trouble of re-entering it upon a subsequent access of the page, we do link information that we store in a cookie to personally identifiable information that you submit. You can remove the cookie by following the directions provided in your Internet browser’s “help” file.

How We Use This Information

We use this information internally to show aggregate activity and determine potential trends in web site usage. OMIC shares this information only with service providers used to administer our website and to provide us usage information.

Voluntarily Submitted Information

In order to request information from OMIC or to access certain pages on our website, you must provide some personal information, including your contact information (e.g. your name, address, and email), Academy membership or other identifying information (e.g. your AAO ID), and insurance policy information (e.g. your policy number and expiration date).

How We Use This Information

We use this information to verify your identity and eligibility and to process or respond to your requests. We may also use this information to update OMIC’s records. All information submitted is used only for OMIC’s business purposes. OMIC shares this information only with service providers used to process or respond to your requests. For example, if you request information about a life or health insurance product, we will share your contact information with Marsh Affinity Group Services, which coordinates the Academy/OMIC life and health insurance program. We do not give your personally identifiable information provided to us online to third parties for commercial purposes or for any other reason not disclosed in this statement. We will never use or share this information in ways not described in this privacy statement without also providing you an opportunity to opt-out or otherwise prohibit such use.

How We Use Your Email Address If your email address was voluntarily submitted to OMIC, in addition to using it to respond to your online requests, we may also use that email address to send you alerts, updates and announcements about your insurance with OMIC, including, but not limited to, underwriting and risk management information. OMIC shares your email address only with service providers used to process or respond to your requests, as explained above. Otherwise, OMIC does not share your email address with any third parties.

How to Unsubscribe

If you do not wish to receive any alerts, updates or announcements from OMIC via email, you may unsubscribe by doing one of the following:

  1. follow the instructions for unsubscribing on any alert, update or announcement email from OMIC, or;
  2. contacting OMIC as indicated below.

How to Change the Information You Have Given Us

If your personally identifiable information changes, you may edit this information either through the OMIC website or by contacting OMIC as indicated below.

How We Protect the Information You Give Us

We use generally accepted industry standards to protect the personally identifiable information we obtain about you through our website. Using a popular and reputable methodology, we are able to securely and reliably encrypt all information you provide to us. This makes it exceedingly difficult for unauthorized intruders to read any transmitted data. However, no method of transmission over the Internet, or method of electronic storage, is 100% secure. Therefore, while we strive to protect your personally identifiable information, we cannot guarantee its absolute security.

Links to and from Other Web Sites

The privacy practices described in this statement are OMIC’s only; we are not responsible for the privacy practices of any companies whose websites are linked to or from the OMIC website. We encourage you to be aware when you leave our site and to read the privacy statements of all other websites.

Legal Disclaimer

We reserve the right to disclose your personally identifiable information as required by law and when we believe that disclosure is necessary to protect our rights or to comply with a judicial proceeding, court order, or legal process.

Changes to the Privacy Statement

We reserve the right to modify this privacy statement at any time, so please review it frequently. If we make changes to our privacy policies or practices, we will amend the privacy statement to reflect those changes and post the revised version on our website.

How to Contact Us

If you have any questions about this privacy statement or any of OMIC’s privacy practices or policies, please email omic@omic.com, call (800) 562-6642, fax (415) 771-1095, or write to us:

OMIC
655 Beach Street San Francisco, CA 94109.

OMIC, not the Academy, is solely responsible for all insurance and business decisions including coverage, underwriting, claims and defense decisions.

OMIC Forms 43rd Educational Alliance with the Michigan Society of Eye Physicians and Surgeons (MiSEPS)

This cooperative venture will significantly reduce malpractice premiums for MiSEPS members by offering a 10% discount (averaging more than $1,300) to members for attending a qualifying cosponsored risk management event. CME credit available for some courses.

For more information on OMIC’s CV program contact Deena Mader at OMIC at 800-562-6642, ext. 628. www.omic.com

For Michigan state society membership, please contact Theresa Wiley, Associate Director for the Society at 313 823 1000 or email at twiley@miseps.org.

Visit the MiSEPS website for more info: www.MiSEPS.org.

Several New and Revised Consent Forms Published by OMIC

Several new and revised informed consent documents and risk management recommendations documents were recently uploaded.

CATARACT SURGERY

  • New: Same Day Sequential Bilateral Surgery Addendum
  • New: Femtosecond Laser Cataract Surgery Addendum

RETINA

  • New: Intravitreal Anti-VEGF Injections for Adults: Risk Management Recommendations
  • Revised: AvastinTM (bevacizumab) Consent
  • Revised: EyleaTM (aflibercept) Consent
  • Revised: LucentisTM (ranibizumab) Consent
  • Revised: OzurdexTM (dexamethasone) Consent

RETINOPATHY OF PREMATURITY

  • New: Intravitreal Anti-VEGF Injections for ROP: Risk Management Recommendations
  • Revised: Intravitreal Anti-VEGF Injections for ROP Consent

See all new consent forms here.

See all new risk management recommendation guides here.

OMIC policyholders who adminster intravitreal anti-VEGF (IVAV) injections for ROP are strongly encouraged to review these forms and contact OMIC Risk Manager Anne M. Menke, RN, PhD, if you use IVAV for indications not listed on the consent form, or if you have any questions about ROP. She may be reached at 1.800.562-6642, extension 651 or amenke@omic.com.

Pages:«1...9101112131415...22»




Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.

61864684